Reply

Affiliations

¹ Division of Gastroenterology and Hepatology, The Johns Hopkins University School of Medicine, Baltimore, MD.
² Division of Infectious Disease, The Johns Hopkins University School of Medicine, Baltimore, MD.
³ Department of Transplant Surgery, The Johns Hopkins University, Baltimore, MD.

Comment

Behnam Saberi et al. Hepatology. 2018 Mar.

. 2018 Mar;67(3):1183-1184.

doi: 10.1002/hep.29703. Epub 2018 Jan 30.

¹ Division of Gastroenterology and Hepatology, The Johns Hopkins University School of Medicine, Baltimore, MD.
² Division of Infectious Disease, The Johns Hopkins University School of Medicine, Baltimore, MD.
³ Department of Transplant Surgery, The Johns Hopkins University, Baltimore, MD.

No abstract available

Comment on

Challenges in treatment of hepatitis C among patients with hepatocellular carcinoma.
Saberi B, Dadabhai AS, Durand CM, Philosophe B, Cameron AM, Sulkowski MS, Gurakar A. Saberi B, et al. Hepatology. 2017 Aug;66(2):661-663. doi: 10.1002/hep.29126. Epub 2017 Jun 24. Hepatology. 2017. PMID: 28211073 No abstract available.
Hepatocellular carcinoma decreases the effectiveness of hepatitis C antiviral treatment: Do direct-acting antiviral regimens matter?
Ji F, Yeo YH, Wei MT, Wei B, Dang S, Li Z, Nguyen MH. Ji F, et al. Hepatology. 2018 Mar;67(3):1180-1182. doi: 10.1002/hep.29701. Epub 2018 Jan 30. Hepatology. 2018. PMID: 29194694 No abstract available.